News

Verywell Health17m
Ohtuvayre: The First Novel COPD Treatment Approved in Over a Decade
Ohtuvayre is the first new inhaled COPD therapy approved in over two decades. COPD is a chronic inflammatory condition that ...
Thorax2d
Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline
Background Muscle wasting and weakness (sarcopenia) are commonly associated with COPD causing frailty and reduced quality of ...